The share price of UnitedHealth Group Incorporated (NYSE: 
UNH) is up 4% in Tuesday's premarket session as the company reports earnings results 28 October, 2025 before the bell.
UnitedHealth Group raised its 2025 earnings outlook to reflect net earnings of at least $14.90 per share and adjusted net earnings of at least $16.25 per share.
Third Quarter 2025 Key Performance Metrics
Consolidated revenues of $113.2 billion, up 12% year-over-year.
Earnings from operations were $4.3 billion; net margin of 2.1%.
Adjusted EPS of $2.92; GAAP EPS of $2.59.
Medical care ratio (MCR) of 89.9% was in line with expectations outlined in the second quarter 2025.
Operating cost ratio of 13.5% reflecting investments to support future growth.
UnitedHealthcare revenues grew 16% year-over-year to $87.1 billion, driven by growth in Medicare & Retirement and Community & State; UnitedHealthcare served 50.1 million consumers domestically, up 795,000 year-over-year.
Optum revenues grew 8% year-over-year to $69.2 billion, driven by growth in Optum Rx.
September 30, 2025, debt-to-capital ratio of 44.1% unchanged from the second quarter 2025 and inclusive of the impact of closing the Amedisys transaction on August 14, 2025.
Technical Outlook
With the RSI at 58,UNH is poised to break the $381 resistant zone paving the way for a much more greater strides. Similarly, on a more bullish tone, the stock's moving averages have cross paths indicating possible resurgence of a golden cross.
UNH) is up 4% in Tuesday's premarket session as the company reports earnings results 28 October, 2025 before the bell.UnitedHealth Group raised its 2025 earnings outlook to reflect net earnings of at least $14.90 per share and adjusted net earnings of at least $16.25 per share.
Third Quarter 2025 Key Performance Metrics
Consolidated revenues of $113.2 billion, up 12% year-over-year.
Earnings from operations were $4.3 billion; net margin of 2.1%.
Adjusted EPS of $2.92; GAAP EPS of $2.59.
Medical care ratio (MCR) of 89.9% was in line with expectations outlined in the second quarter 2025.
Operating cost ratio of 13.5% reflecting investments to support future growth.
UnitedHealthcare revenues grew 16% year-over-year to $87.1 billion, driven by growth in Medicare & Retirement and Community & State; UnitedHealthcare served 50.1 million consumers domestically, up 795,000 year-over-year.
Optum revenues grew 8% year-over-year to $69.2 billion, driven by growth in Optum Rx.
September 30, 2025, debt-to-capital ratio of 44.1% unchanged from the second quarter 2025 and inclusive of the impact of closing the Amedisys transaction on August 14, 2025.
Technical Outlook
With the RSI at 58,
UNH is poised to break the $381 resistant zone paving the way for a much more greater strides. Similarly, on a more bullish tone, the stock's moving averages have cross paths indicating possible resurgence of a golden cross. 
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.